Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Aridis Pharmaceuticals Inc.

0.0002
-0.0021-91.30%
Volume:5.53K
Turnover:1.11
Market Cap:8.91K
PE:-0.01
High:0.0002
Open:0.0002
Low:0.0002
Close:0.0023
52wk High:0.0500
52wk Low:0.0000
Shares:44.57M
Float Shares:37.96M
Volume Ratio:0.61
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0399
EPS(LYR):-1.6174
ROE:415.66%
ROA:-4.40%
PB:-0.00
PE(LYR):0.00

Loading ...

OverviewCompanyNewsFilings

Healios Prioritizes ARDS Clinical Trials Over Stroke Lead Drug HLCM051

MT Newswires Live
·
Dec 09

MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

GlobeNewswire
·
Dec 08

Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment

TIPRANKS
·
Oct 28

Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody

GlobeNewswire
·
Sep 25

Press Release: MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development

Dow Jones
·
Sep 18

MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND

GlobeNewswire
·
Sep 16

The Concentration of Ten-Fold Bull Stocks in This Bull Market

Deep News
·
Aug 23

Press Release: Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board

Dow Jones
·
Jul 14

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
Nov 03, 2023 Post Market
Delist
Jul 19, 2023
Financial Report Announcement
Jun 08, 2023 Post Market
Financial Report Announcement
May 22, 2023 Post Market
Financial Report Announcement
Nov 21, 2022 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.39
Current
-2.08
Sector Average
92.48%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.39
Maximum
-0.20
+1 STD
-0.75
Minimum
-3.70
-1 STD
-3.42
Average
-2.08

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.